Latest Press Releases

Timor-Leste Eliminates Lymphatic Filariasis as a Public Health Problem

DECATUR, Ga., Nov. 12, 2024 (GLOBE NEWSWIRE) -- The Mectizan Donation Program applauds Timor-Leste for eliminating lymphatic filariasis (LF) as a public health problem, a remarkable achievement that was recently validated by the World Health ...

Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative Join forces to Combat Vision loss from Diabetes

·More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1 ·DRD is a growing epidemic that is expected to increase as the ...

7 Key Tips and Steps to Finding a Therapist

Finding the right therapist can be a big decision. Whether you’re dealing with stress, navigating life changes, or seeking deeper self-understanding, having a supportive, qualified therapist can make all the difference. But how do you go about ...

Mind Lab Pro Review: Does This Nootropic Supplement Work?

If life just feels too demanding, an evidence-based nootropic such as Mind Lab Pro may help. Read more here about Mind Lab Pro reviews, ingredients, and price. It’s time to get serious about your professional life or boost your performance, but ...

Io Therapeutics, Inc., Announces Presentation of Data on its RAR Gamma Agonist Compound IRX5010 Demonstrating Inhibition of Tumor Infiltrating Myeloid derived Suppressor cells, Promotion of Tumor Infiltrating T-cells, and Effective Tumor Growth Inhibition in Murine Models of Breast, Colorectal, and Prostate cancers

SPRING, Texas, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., presented results from studies done in breast, colorectal, and prostate cancer models with the company’s newest anti-cancer compound IRX5010, an agonist of the retinoic ...

Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance

PR Newswire NEW YORK, Nov. 13, 2024 NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology company based out of New York and Bangalore, announced the 510(k) clearance of the Frontier X Plus from the U.S. FDA. The ...

ImageBiopsy Lab launches IB Lab FROG: AI-powered Foot Measurements for Orthopedic Insights

PR Newswire VIENNA, Nov. 13, 2024 VIENNA, Nov. 13, 2024 /PRNewswire/ -- ImageBiopsy Lab, a leading provider of AI-powered musculoskeletal imaging solutions, has launched IB Lab FROG. This AI module, CE-cleared under the European Medical ...

Understanding Diabetes: HME Square Inc. is featured on Viewpoint with Dennis Quaid

PR Newswire MIAMI, Nov. 13, 2024 Millions of people across the United States navigate the challenges of diabetes, a complex condition that requires ongoing management. Viewpoint with Dennis Quaid sheds light on this journey, featuring HME ...

Cat Owners are Worried: New Survey Finds 54% of Cat Owners are Concerned about Litter Box Habits

PR Newswire MUSCATINE, Iowa, Nov. 13, 2024 World's Best Cat Litter® Introduces First Veterinary Approved Blood Detecting Litter Box Monitoring Solution: Health Check-In™ Boosters™ Litter Additive MUSCATINE, Iowa , Nov. 13, 2024 ...

Holiday Pie of Pet Dangers

PR Newswire MINNEAPOLIS, Nov. 13, 2024 Pet Toxicology Experts Slice Up a List of Common Yuletide Toxins MINNEAPOLIS, Nov. 13, 2024 /PRNewswire/ -- The perfect holiday season is filled with food, fun, family and friends. For your pets, ...

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

PR Newswire VICTORIA, BC, Nov. 12, 2024 VICTORIA, BC, Nov. 12, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company developing precision drug ...

Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight

PR Newswire LAS VEGAS, Nov. 12, 2024 After over a decade without notable progress in treating chronic obstructive pulmonary disease, patients with this ongoing condition now have two new treatment options, with more expected in the future. ...

Wound Care Market to Expand by USD 6.95 Billion (2024-2028), Revenue Boosted by Rising Acute and Chronic Cases, AI-Driven Report Highlights Market Shifts - Technavio

PR Newswire NEW YORK, Nov. 12, 2024 NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global wound care market size is estimated to grow by USD 6.95 billion from 2024-2028, according to Technavio. The ...

Government of Canada increases reach of Canada Student Loan forgiveness for nurses and doctors in underserved rural and remote communities

Canada NewsWire SHEET HARBOUR, NS, Nov. 12, 2024 SHEET HARBOUR, NS, Nov. 12, 2024 /CNW/ - Canada is facing a shortage of health professionals, particularly in rural and remote communities that face unique challenges attracting and retaining ...

Get Gambit Redefines Men's Health with Convenient and Discreet Care, Specializing in Testosterone Replacement Therapy

Canada NewsWire TORONTO, Nov. 12, 2024 TORONTO, Nov. 12, 2024 /CNW/ - Get Gambit, a leading provider of healthcare solutions for men across Canada, is transforming the way men address critical health concerns. By offering discreet, ...

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

PR Newswire SAN DIEGO, Nov. 12, 2024 Results to be Featured in Oral Late Breaker Presentation SAN DIEGO, Nov. 12, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company ...

Unlocking Hormone Health: Life Time to Host Complimentary Men's Hormone Health Livestream Nov. 13

PR Newswire CHANHASSEN, Minn., Nov. 12, 2024 Open to anyone via the Life Time App at Noon CT CHANHASSEN, Minn., Nov. 12, 2024 /PRNewswire/ -- Life Time (NYSE: LTH), which continues to innovate in the performance and longevity space ...

Annual Scientific Sessions for the Prevention of Cardiovascular Disease Coming to Boston's Seaport District August 2025

PR Newswire HOUSTON, Nov. 12, 2024 Pre-conference Course and General Session Registration Announcement for the American Society for Preventive Cardiology HOUSTON, Nov. 12, 2024 /PRNewswire/ -- The American Society for Preventive ...

My Green Mattress Announces Incredible Black Friday Sale: Give the Gift of Healthy Sleep

PR Newswire CHICAGO, Nov. 12, 2024 CHICAGO, Nov. 12, 2024 /PRNewswire/ -- My Green Mattress announces the biggest discounts of the year for their Black Friday Sale. Customers can enjoy exclusive pricing on premium, eco-friendly mattresses ...

Hunched App Expands to Android, Launches Updated iOS Version to Combat Text Neck Epidemic

PR Newswire MIAMI, Nov. 12, 2024 The App Expands its Commitment to Fight Text Neck with its Latest Innovation MIAMI, Nov. 12, 2024 /PRNewswire/ -- In today's digital age, posture-related issues like "Text Neck" and "Forward Head Posture" ...

Researchers uncover new role of mutant proteins in some of the deadliest cancers

PR Newswire BETHESDA, Md., Nov. 12, 2024 Findings could point to new ways to treat RAS-driven cancers BETHESDA, Md., Nov. 12, 2024 /PRNewswire/ -- Researchers at the National Institutes of Health (NIH) and their collaborators have ...

Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia

Canada NewsWire MISSISSAUGA, ON, Nov. 12, 2024 MISSISSAUGA, ON, Nov. 12, 2024 /CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or disease-related symptoms, in adult ...

Neurologists Describe Early Detection of Alzheimer's Disease as 'Critical' for New Treatments

PR Newswire WASHINGTON, Nov. 12, 2024 Detection of Alzheimer's disease in its early stages is crucial to initiating treatment WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- The availability of amyloid-reducing therapies now makes detection of ...

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

PR Newswire BEIJING, Nov. 12, 2024 BEIJING, Nov. 12, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the positive topline results of a Phase 1 clinical trial its oral glucagon-like ...

Access Accelerated and the World Bank Collaborate via New Technical Partnership in Cooperation with Results for Development to Build a Coalition Aimed at Closing the Health Financing Gap for Noncommunicable Diseases in Low and Middle-Income Countries

PR Newswire GENEVA and LILONGWE, Malawi, Nov. 12, 2024 GENEVA and LILONGWE, Malawi, Nov. 12, 2024 /PRNewswire/ -- Today marks the launch of a transformative initiative as Access Accelerated and the World Bank come together in a new technical ...

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

PR Newswire REYKJAVIK, Iceland, Nov. 12, 2024 REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower ...

EDAN Unveils Latest Innovations for Global Healthcare at MEDICA 2024

PR Newswire DUSSELDORF, Germany, Nov. 12, 2024 DUSSELDORF, Germany, Nov. 12, 2024 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its latest product innovations at ...

U.S. News & World Report Publishes 2025 Best Nursing Homes Ratings

PR Newswire WASHINGTON, Nov. 12, 2024 One in five U.S. nursing homes rated as "Best." WASHINGTON, Nov. 12, 2024 /PRNewswire/ -- U.S. News & World Report, the global authority in health care rankings and consumer advice, today announced ...

7 Key Tips and Steps to Finding a Therapist

Finding the right therapist can be a big decision. Whether you’re dealing with stress, navigating life changes, or seeking deeper self-understanding, having a supportive, qualified therapist can make all the difference. But how do you go about ...

Local Dermatology Clinic Hosts Successful American Red Cross Blood Drive on Veterans Day to Help With Blood Shortage

PR Newswire ROSEVILLE, Minn., Nov. 11, 2024 ROSEVILLE, Minn., Nov. 11, 2024 /PRNewswire/ -- Local dermatology clinic, Tareen Dermatology proudly hosted the American Red Cross for a community blood drive on Veterans Day. The event drew a ...

Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial

PR Newswire SHANGHAI, Nov. 11, 2024 – The MANEUVER study met the primary endpoint with an objective response rate (ORR) at week 25 of 54.0% compared with 3.2% for placebo (p SHANGHAI, Nov. 11, 2024 /PRNewswire/ -- Abbisko today announced ...

Bunkerhill Health AI Powers Cardiovascular Screening at Stamford Health

PR Newswire SAN FRANCISCO, Oct. 21, 2024 SAN FRANCISCO, Oct. 21, 2024 /PRNewswire/ -- Stamford Health's Heart & Vascular Institute has announced it will be the first in Connecticut to offer a new, AI-powered cardiovascular screening ...

Veterinary Artificial Insemination Market to Grow by USD 962.3 Million from 2024-2028, as Livestock Multiplication Drives Demand with AI Impact on Market Trends - Technavio

PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global veterinary artificial insemination market size is estimated to grow by USD 962.3 million from 2024-2028, ...

Dental Practice Management Software Market to Grow by USD 954.53 Million from 2024-2028, as Demand for Maximized Chair Utilization Rises with AI-Powered Evolution - Technavio

PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global dental practice management software market size is estimated to grow by USD 954.53 million from ...

Triumvira Immunologics' Late-Breaking Abstract Selected for Oral Presentation at the 39th SITC Annual Meeting Demonstrates Preliminary Safety and Promising Clinical Activity of TAC01-CLDN18.2 Cell Therapy in Patients with Solid Tumors

PR Newswire HOUSTON and SAN DIEGO, Nov. 11, 2024 TAC01-CLDN18.2 was well tolerated, with no dose-limiting toxicities and a favorable safety profile in the first two cohorts of the ongoing trial A pancreatic cancer patient treated with ...

Latest Press Releases

Premium Press Releases »

Timor-Leste Eliminates Lymphatic Filariasis as a Public Health Problem

Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative Join forces to Combat Vision loss from Diabetes

7 Key Tips and Steps to Finding a Therapist

Mind Lab Pro Review: Does This Nootropic Supplement Work?

Press Releases »

Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance

ImageBiopsy Lab launches IB Lab FROG: AI-powered Foot Measurements for Orthopedic Insights

Understanding Diabetes: HME Square Inc. is featured on Viewpoint with Dennis Quaid

Cat Owners are Worried: New Survey Finds 54% of Cat Owners are Concerned about Litter Box Habits

Holiday Pie of Pet Dangers

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Sanofi/Regeneron Pharmaceuticals' DUPIXENT Approval Marks a Significant Shift in Chronic Obstructive Pulmonary Disease Treatment Landscape | DelveInsight

Wound Care Market to Expand by USD 6.95 Billion (2024-2028), Revenue Boosted by Rising Acute and Chronic Cases, AI-Driven Report Highlights Market Shifts - Technavio

Government of Canada increases reach of Canada Student Loan forgiveness for nurses and doctors in underserved rural and remote communities

Get Gambit Redefines Men's Health with Convenient and Discreet Care, Specializing in Testosterone Replacement Therapy

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Unlocking Hormone Health: Life Time to Host Complimentary Men's Hormone Health Livestream Nov. 13

Annual Scientific Sessions for the Prevention of Cardiovascular Disease Coming to Boston's Seaport District August 2025

My Green Mattress Announces Incredible Black Friday Sale: Give the Gift of Healthy Sleep

Hunched App Expands to Android, Launches Updated iOS Version to Combat Text Neck Epidemic

Researchers uncover new role of mutant proteins in some of the deadliest cancers

Ojjaara (momelotinib) approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia

Neurologists Describe Early Detection of Alzheimer's Disease as 'Critical' for New Treatments

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

Access Accelerated and the World Bank Collaborate via New Technical Partnership in Cooperation with Results for Development to Build a Coalition Aimed at Closing the Health Financing Gap for Noncommunicable Diseases in Low and Middle-Income Countries

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

EDAN Unveils Latest Innovations for Global Healthcare at MEDICA 2024

U.S. News & World Report Publishes 2025 Best Nursing Homes Ratings

7 Key Tips and Steps to Finding a Therapist

Local Dermatology Clinic Hosts Successful American Red Cross Blood Drive on Veterans Day to Help With Blood Shortage

Pimicotinib Significantly Improved Outcomes for Patients with Tenosynovial Giant Cell Tumor in a Global Phase III Trial

Bunkerhill Health AI Powers Cardiovascular Screening at Stamford Health

Veterinary Artificial Insemination Market to Grow by USD 962.3 Million from 2024-2028, as Livestock Multiplication Drives Demand with AI Impact on Market Trends - Technavio

Dental Practice Management Software Market to Grow by USD 954.53 Million from 2024-2028, as Demand for Maximized Chair Utilization Rises with AI-Powered Evolution - Technavio

Triumvira Immunologics' Late-Breaking Abstract Selected for Oral Presentation at the 39th SITC Annual Meeting Demonstrates Preliminary Safety and Promising Clinical Activity of TAC01-CLDN18.2 Cell Therapy in Patients with Solid Tumors

Medindia Newsletters